CD4 and B-cell chronic lymphocytic leukemia: Therefore, enhanced STAT3 signaling could contribute to high Bcl-2 expression in treated patients, as we observed significantly higher levels of basal STAT3 phosphorylation in CD4+ T-cells from patients on therapy compared to untreated patients with CLL.